Charcot Marie Tooth Market

1
(No Transcript)
2
Charcot Marie Tooth Disease (CMT)
01
It is a disease of the peripheral nerves that
control muscles (unlike the muscular dystrophies,
which affect the muscles themselves).
02
It is a group of heterogeneous disorders which
affect the motor and sensory peripheral nerves,
resulting in muscle weakness and atrophy.
03
CMT types are distinguished by age of onset,
inheritance pattern, severity, and whether they
are linked to defects in axon or myelin.
04
CMT types are CMT1, CMT2, CMT3, and CMT4. They
are major types of CMT associated with a large
number of subtypes.
05
CMT symptoms are muscle weakness, contractures
and bone deformities, sensory loss and associated
symptoms.

• DelveInsight 2019 All rights reserved

3
CMT Epidemiology
Charcot Marie Tooth total diagnosed prevalent
population in 7 major markets (7MM) was 3,878
cases in 2017. An estimated 150,000 people was
affected in the United States. Among the
European countries, France had the highest CMT
diagnosed prevalent population with 272 cases,
followed by the United Kingdom, which had CMT
diagnosed prevalent population of 228 in 2017.
Whereas Spain had the lowest diagnosed prevalent
population of 84 in 2017. Japan had 73
diagnosed prevalent cases of Charcot Marie Tooth
in 2017.
7MM- USA, EU-5(Germany, Spain, Italy, France
and UK), Japan

• DelveInsight 2019 All rights reserved

4
CMT Market Outlook
Despite the fact that there is no currently
approved therapies for CMT treatment and that
CMT market is entirely dependent on off-label
therapies and procedural management, companies
have not yet shifted their focus towards this
therapeutic area.
The United States had the highest Charcot Marie
Tooth market size in 2017 that accounts for
approximately 47 of the total market.
Overall, the increasing CMT prevalence, awareness
and emerging CMT pipeline therapies will propel
CMT market size forward during the forecasted
period.
Spain accounted for the least Charcot Marie Tooth
market share (8.62) among the 7MM countries.

• DelveInsight 2019 All rights reserved

5
CMT Emerging Therapies and Companies
01
Drug- PXT3003 Company- Pharnext
02
Drug- MD1003 Company- MedDay Pharmaceuticals
03
Drug- ACE-083 Company- Acceleron

• DelveInsight 2019 All rights reserved

6
Complete Information
For complete information on
Charcot Marie Tooth (CMT) Market Insights,
Epidemiology and Market Forecast - 2027 please
click the link below
CLICK HERE
OR
Write Us At 
info_at_delveinsight.com

• DelveInsight 2019 All rights reserved

7
About DelveInsight
2
1
3

• DelveInsight 2019 All rights reserved

8
Services by DelveInsight

• DelveInsight 2019 All rights reserved

9
Contact Us
info_at_delveinsight.com
91-11-4568 9769
www.delveinsight.com
blog/delveInsight/
twitter/delveInsight
LinkedIn/delveInsight

• DelveInsight 2019 All rights reserved